Q2 2026 saw 10.2% revenue growth and 19.1% higher adjusted EPS, driven by strong organic demand across channels. Full-year guidance was raised, with adjusted EPS now expected at $11.05–$11.25 and revenue at $11.95B–$12.05B.Original document: Quest Diagnostics Incorporated [DGX] Slides Release — Jul…
Q2 2026 saw 10.2% revenue growth and 19.1% higher adjusted EPS, driven by strong organic demand across channels. Full-year guidance was raised, with adjusted EPS now expected at $11.05–$11.25 and revenue at $11.95B–$12.05B.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
